BioSpace News Archive

OrigiMed: The largest cohort study on HBV-Related hepatocellular carcinoma in China released in Cell

The world-class journal Cell, an international high-impact journal, published the article “Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma in China.”

October 22, 2019
·
4 min read
Business

OraSure Technologies Earnings Conference Call Invitation2019 Third Quarter Earnings Conference Call Wednesday, November 6, 2019, 5:00 p.m. ET

OraSure Technologies, Inc. has scheduled its regular earnings conference call covering 2019 third quarter financial results, updated financial guidance and certain business developments for 5:00 pm ET on Wednesday, November 6, 2019..

October 22, 2019
·
1 min read
BioCapital

Comprehensive Study of Americans’ Attitudes on Health Care Uncovers Deep Concern About Costs, Candidate Proposals and the Opioid Epidemic

The Physicians Foundation released its biennial Survey of America’s Patients, revealing the biggest hurdles facing Americans in our country’s expensive and hard to navigate health care system.

October 22, 2019
·
6 min read
Business

Quest Diagnostics Reports Third Quarter 2019 Financial Results

Third quarter reported diluted earnings per share from continuing operations (“EPS”) of $1.56, up 2.8% from 2018; and adjusted diluted EPS of $1.76, up 4.8% from 2018

October 22, 2019
·
20 min read
FDA

Eton Pharmaceuticals Announces U.S. FDA Approval of Biorphen® (phenylephrine HCI) Injection

Eton Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has approved Biorphen®, the first and only FDA-approved ready-to-use formulation of phenylephrine for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia.

October 22, 2019
·
7 min read
Business

CollPlant CEO Yehiel Tal Appointed to Serve on International Society for Biofabrication’s Industry Relations Committee

The Industry Relations Committee represents all aspects of Biofabrication including roadmap, technologies, cell biology, large scale manufacturing, regulation, and commercialization

October 22, 2019
·
6 min read
Drug Development

Provention Bio Reports Top Line Results from Phase 2a PRINCE Clinical Trial with PRV-6527, an Oral CSF-1R Inhibitor, in Patients with Moderate to Severe Crohn’s Disease

Excellent Safety Profile and Improvements in Clinically Relevant Secondary Endpoints (Endoscopy and Histology) Support Further Development by a Partner

October 22, 2019
·
6 min read
Pharm Country

Acorda Launches New Tool for People with Parkinson’s to Improve Communication About OFF Periods

“Do Tell” Your Doctor Tool was adapted from a clinically validated questionnaire developed by Duke University, with input from the Parkinson’s community

October 22, 2019
·
7 min read
Drug Development

CheckMate -9LA, a Phase 3 Trial Evaluating Opdivo (nivolumab) Plus Low-Dose Yervoy (ipilimumab) Combined with Chemotherapy, Meets Primary Endpoint Demonstrating Superior Overall Survival Compared to Chemotherapy Alone in First-Line Lung Cancer

Study evaluated Opdivo plus low-dose Yervoy given concomitantly with two cycles of chemotherapy vs. chemotherapy alone for the first-line treatment of advanced non-small cell lung cancer

October 22, 2019
·
35 min read
Business

John McCabe Joins Oncorus, Inc. as Chief Financial Officer

Seasoned industry finance executive to help guide Oncorus as it advances toward the clinic and progresses next-generation viral immunotherapies

October 22, 2019
·
2 min read